Nuvectis Pharma inc (NVCT) Annual Balance Sheets

Annual · GAAP · USD millions
Access NVCT quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Nuvectis Pharma inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2021)
Assets
Cash & cash equivalent31.63
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments31.00
Other Current Assets0.07
Total Current Assets31.71
Tax Assets, Noncurrent0.00
Total Assets31.71
Liabilities
Accounts Payable, Current AC6.27
Accrued Liabilities, Current7.02
Total Current Liabilities13.30
Total Long-term Debt0.00
Total Liabilities13.30
Stockholders' Equity
Additional Paid In Capital Common Stock118.10
Retained Earnings / Accumulated Deficit-99.69
Common Stockholder's Equity18.41
Non-controlling interests & other0.00
Total Stockholder's Equity18.41
Liabilities & Stockholder's Equity31.71
4 historic quarters locked

Sign in to unlock the full Nuvectis Pharma inc balance sheet history.

About Nuvectis Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-013044

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License